The global flow
cytometry market is expected to witness a CAGR of ~9% during
the forecast period. High incidence and prevalence of HIV/AIDS and
cancer, growing focus on immunology and immuno-oncology research, advent of AI
platforms in flow cytometry workflows, increase in R&D investment to
develop multicolor assays and advanced reagents are some of the key factors
driving the market growth. However, higher costs of flow cytometry products is
a major constraint for the growth of the flow cytometry market.
Flow cytometry is a technique used to detect and
measure physical and chemical characteristics of a population of cells or
particles usually suspended in a fluid using a laser beam. The technique helps
in understanding the structure and composition of cells for chromosome
analysis, cancer diagnosis, protein expression, diagnosis of diseases and
hematological malignancies.
Most common types of flow cytometry-based proliferation
assays are cell-based and bead-based assays. Today, cell-based
assays are used in more than half of all high-throughput drug screenings for
target validation and ADMET (absorption, distribution, metabolism, elimination
and toxicity) in the early stage of drug discovery due to its enhanced accuracy
and portability. On the other hand, Bead-based assays are used to study
infectious diseases. Owing to advancements in molecular engineering and
monoclonal antibody production, the demand for these assays is expected to rise
in the coming years.
Furthermore, improvements in fluorescent dyes, advancements
in multicolor flow cytometry (which finds extensive applications in new drug
development), development of advanced reagents and AI based software platforms
and algorithms are fueling the growth of the market.
Unlock key findings! Fill out a quick inquiry to access a
sample report
https://meditechinsights.com/flow-cytometry-market/request-sample/
Rise in chronic disease increases flow cytometry
utilization
Rising prevalence of chronic diseases such as cancer,
HIV/AIDS, hematological malignancies and others is fueling the growth of the
global flow cytometry market. Flow cytometry is considered an efficient tool
for clinically diagnosing these diseases. The developments in immunology and
other areas of cancer research have immensely contributed to the use of flow
cytometry. Growing preference by health specialists to use allergenic and
autologous stem cell therapies instead of radiation and chemotherapies is another
key factor driving the market. Rising R&D investment by biotech and
biopharma companies to introduce new technologies is also expected to propel
the global flow cytometry market. For instance,
- In
May 2024, Agilent Technologies introduced the NovoCyte Opteon Spectral
Flow Cytometer, a system comprising 3-5 lasers, 73 detectors, enabling
high-dimensional analysis of over 40 cellular markers with user-friendly
software for diverse research applications
- In
March 2024, Beckman Coulter Life Sciences launched the CytoFLEX Nano Flow
Cytometer, an advanced platform optimized for high-sensitivity detection
and characterization of extracellular vesicles and nanoparticles,
providing researchers with enhanced resolution and analytical capabilities
Growing adoption of flow cytometry in stem cell research
Flow cytometry and cell sorting are critical tools
in stem cell research. Recent advances in flow cytometric hardware, reagents
and software have synergized to permit the stem cell biologist to better
identify and isolating rare cells based on their immunofluorescence and light
scattering characteristics. In contrast to other methods, such as Western blot
and cellular imaging, multicolor flow cytometry enables researchers to
interrogate heterogeneous cell populations and analyze their subpopulations. By
using multiple fluorescent-labelled antibodies, researchers can obtain robust
data and population-based statistics on differentiating stem cell cultures and
isolate stem cells and their derivatives from primary tissue and diverse
in-vitro populations.
There has been extraordinary growth in stem cell research
and related applied clinical practices. The current flow cytometry applications
in clinical research include emphasizing immunophenotyping, enumerating
reticulocyte, reticulated platelet, multiple drug resistance assays, cell
function assays and apoptosis. During pandemic, stem cell-based therapies were
also recommended to manage or treat COVID-19 infections. The growing market
penetration in stem cell research, adoption of recombinant DNA technology for
antibody production, and evolution of tandem flow cytometry technologies is
expected to open growth opportunities in the market.
“Flow Cytometry is turning researchers into molecular
detectives and helping them to delve into the depths of diseases. It
allows researchers and scientists to probe the more complex and transient
cellular changes that underpin the course of disease and responses to
treatment, helping them better select the right drug target”.
- Senior Director, Data Sciences & Quantitative
Biology, Pharmaceutical & Biotechnology Company, United States
North America leads in terms of adoption of the flow
cytometry market
North America dominates the global flow cytometry market,
followed by Europe. Growing research activities, well-established
infrastructure, rising drug discovery and development and presence of leading
pharmaceutical companies in this region are some of the key factors driving the
market growth.
In Asia Pacific, emerging economies like India and China are
anticipated to grow significantly over the forecast period. Improving research
infrastructure, adopting the latest technology and government support for
establishing the pharmaceutical industry is likely to fuel the demand for the
flow cytometry market in this region.
Competitive Landscape Analysis
The global flow cytometry market is marked by the presence
of established and emerging market players such as Becton, Dickinson
and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; DiaSorin
S.p.A; Agilent Technologies, Inc.; Sony Group Corporation; Bio-Rad
Laboratories, Inc.; Miltenyi Biotec GmbH; Apogee Flow Systems Ltd.; BioMérieux
S.A.; Cytek Biosciences, Inc.; NanoCellect Biomedical, Inc., among
others. Some of the key strategies adopted by market players include new
product development, strategic partnerships and collaborations, and geographic
expansion.
Get exclusive
insights - download your sample report today
https://meditechinsights.com/flow-cytometry-market/request-sample/
Global Flow Cytometry Market Segmentation
This report by Medi-Tech Insights provides the size
of the global flow cytometry market at the regional- and country-level
from 2023 to 2030. The report further segments the market based on product,
technology, application, and end-user.
Market Size & Forecast (2023-2030), By Product, USD
Million
- Instruments
- Cell
Sorters
- Cell
Analyzers
- Reagents
& Consumables
- Software
- Accessories
Market Size & Forecast (2023-2030), By Technology,
USD Million
- Cell-based
- Bead-based
Market Size & Forecast (2023-2030), By Application,
USD Million
- Research
- Clinical
- Industrial
Market Size & Forecast (2023-2030), By End-user, USD
Million
- Hospitals
- Academic
& Research Institutes
- Biopharma
Companies
- Clinical
Labs
- Others
Market Size & Forecast (2023-2030), By Region, USD
Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research combined
with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply
side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment